SN6
SHORT NOTE
5M
★ High-yield
Classify vaccines. Describe immunisation in India and passive immunisation.
Classification of Vaccines
| Type | Examples | Features |
|---|---|---|
| Live attenuated | BCG, oral polio (OPV), measles-mumps-rubella, varicella, rotavirus, yellow fever, typhoid Ty21a | Strong and long-lasting immunity, often after one dose; but contraindicated in pregnancy and immunosuppression, and they require a cold chain |
| Killed / inactivated | Injectable polio (IPV), rabies, hepatitis A, influenza, whole-cell pertussis, cholera | Safe in immunosuppression; weaker, so boosters and adjuvants are needed |
| Subunit / toxoid | Hepatitis B (recombinant surface antigen), tetanus and diphtheria toxoids, acellular pertussis, HPV | Very safe; require boosters |
| Conjugate | Haemophilus influenzae b, pneumococcal, meningococcal | A polysaccharide linked to a protein carrier, which converts a T-independent response into a T-dependent one — this is what makes them work in infants under 2, in whom plain polysaccharide vaccines fail |
| MRNA and viral vector | COVID-19 vaccines | Rapid development; the platform can be adapted to a new pathogen quickly |
CLINICAL PEARL
Conjugation solved a problem specific to infants. Plain polysaccharide antigens provoke a T-cell-independent response, which the immature infant immune system mounts poorly and without memory. Linking the polysaccharide to a protein carrier recruits T-cell help, producing memory and a boostable response — and it also reduces nasopharyngeal carriage, so vaccinated children stop transmitting and herd immunity protects those too young to be vaccinated.
Immunisation in India
- The Universal Immunisation Programme provides BCG, hepatitis B, oral and injectable polio, pentavalent (DPT with hepatitis B and Hib), rotavirus, pneumococcal conjugate, measles-rubella, JE in endemic districts, and DPT and TT boosters, free of charge
- Mission indradhanush targets children and pregnant women who have been missed, and has substantially raised full immunisation coverage
- India was certified polio-free in 2014, an achievement resting on mass campaigns, surveillance and social mobilisation rather than on any new vaccine
- The cold chain is the practical limiting factor — most vaccines are damaged by heat, and some (OPV) by freezing; vaccine vial monitors indicate cumulative heat exposure
- Adverse events following immunisation (AEFI) must be reported and investigated; distinguishing a genuine vaccine reaction from a coincidental event or a programme error (wrong diluent, unsterile injection) is essential, since a mishandled investigation damages public confidence far beyond the individual case
Passive Immunisation and Immunomodulators
| Agent | Use |
|---|---|
| Immunoglobulins — specific | Tetanus, rabies, hepatitis B, varicella-zoster, anti-D — give immediate but temporary protection, and are used with the vaccine in post-exposure prophylaxis |
| Normal immunoglobulin (IVIg) | Primary immunodeficiency; immune thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease |
| Antivenom, antitoxin | Snake envenomation, diphtheria, botulism |
| Interferons | Interferon-alpha in hepatitis B and some malignancies; beta in multiple sclerosis |
| Immunostimulants | BCG instillation in superficial bladder cancer; levamisole; colony-stimulating factors |
| Immunosuppressants | Calcineurin inhibitors, corticosteroids, azathioprine, mycophenolate, biologicals — transplantation and autoimmune disease |
Applied Aspects
- Live vaccines are contraindicated in pregnancy and significant immunosuppression, and should be given at least 4 weeks before planned immunosuppression or 3 months after stopping it
- Vaccinate before immunosuppression wherever possible — before transplantation, splenectomy, biological therapy or chemotherapy
- Minor illness is not a contraindication; deferring immunisation for a coryza is a major cause of missed opportunity, and the child may not return
- Rabies post-exposure prophylaxis — thorough wound washing with soap and water for 15 minutes, vaccine, and immunoglobulin infiltrated into the wound for category III exposure. India has a large rabies burden and the disease is invariably fatal once established, yet entirely preventable
- Address vaccine hesitancy with respect and evidence; dismissing concerns entrenches them, and trust in the vaccinator is what determines uptake
- Anaphylaxis after vaccination is rare but must be prepared for — adrenaline available, and observation for 15 to 30 minutes afterwards
All questions in Miscellaneous: Toxicology & Therapeutics
- Q1Describe the general principles of management of acute poisoning including decontamination, enhanced elimination, antidotes and toxidromes. ★
- Q2Describe organophosphate poisoning and snake envenomation with their features and management. ★
- Q3Classify the routes of drug administration. Compare their advantages and disadvantages and describe the newer drug delivery systems. ★
- Q4Describe the phases of drug development and the design and ethics of clinical trials. Add a note on pharmacogenomics. ★
- Q5Classify the vitamins. Describe their functions, deficiency states and therapeutic uses. ★
- SN1Define rational prescribing. Describe the P-drug concept and the essential medicines concept. ★
- SN2Describe the principles of drug use in pregnancy and lactation with the important teratogens. ★
- SN3Describe the principles of prescribing in the elderly and in children. ★
- SN4Describe the principles of prescribing in renal and hepatic impairment. ★
- SN5Describe the chelating agents and the management of heavy metal poisoning. ★
- SN6Classify vaccines. Describe immunisation in India and passive immunisation. ★
- SN7Describe the principles of topical therapy and the drugs used in common skin disorders.